Eighth Women's Committee held its first working meeting
Release time:
2022-04-12
The Women Workers' Committee is a gender-based employee organization under the leadership of the trade union at the same level to safeguard the rights and interests of female employees, and is the representative of the interests of female employees. Because of the physiological differences between men and women, female workers have legitimate rights and interests and special interests that need to be safeguarded in marriage, childbirth and family relations. At present, the proportion of female employees in each subordinate unit of the group company is respectively as follows: group headquarters 37.5% , daye peak 26.7% , Yunnan peak
32.3%, Guizhou peak 23.33% , pharmaceutical company (excluding north card and Tianjin) 48.78% , international trading company 40.4% , cable Company 35.71% , Health Technology Company 57.58% , and the total proportion of female workers in the group is 40.47% . In the development of the peak, female workers and male workers, played an important role in promoting. This meeting is the first working meeting since the 8th Women's Staff Committee 2021 was established at the end of the year. Zhang Ci, the new director of the women's staff committee, preached the functions and roles of the women's staff committee at the meeting; the participating women's committee members discussed how to safeguard the legitimate rights and interests of female workers, care for the physical and mental health of female workers, improve the skill level of female workers, and further improve the work of female workers. Talk about opinions and make suggestions. In order to expand the influence of the peak female staff committee, give full play to the role of the female staff committee, and do good and practical things for female employees, Zhang Ci proposed that all subordinate units of the group should establish female staff groups as soon as possible, expand the publicity of the female staff committee, strengthen the communication and exchange between female employees in various enterprises, show women's elegant demeanor, improve the status of female employees, and better play their role in the innovation and development of enterprises. Qin Xuping, member of the Party Committee and Secretary of the Discipline Inspection Commission of Group Company, attended the meeting and delivered a speech. He first affirmed the important role of female workers in the process of peak development, and hoped that the female workers would have a higher political position and unite and guide the majority of female workers to listen to the party. The committee members should unify their thinking, strengthen their study and improve themselves. According to the actual situation of each unit to local conditions to carry out female workers activities; with the female staff committee as the platform and medium, unite the majority of female workers and write a new chapter of peak female workers. (Huang
Yuan)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page